A Comprehensive Patient Blood Management Program During Cardiopulmonary Bypass in Patients Over 60 Years of Age
Qiaoni Zhang,Weidong Yan,Sizhe Gao,Xiaolin Diao,Gang Liu,Jing Wang,Bingyang Ji
DOI: https://doi.org/10.2147/cia.s443908
IF: 3.829
2024-03-07
Clinical Interventions in Aging
Abstract:Qiaoni Zhang, 1 Weidong Yan, 2 Sizhe Gao, 3 Xiaolin Diao, 4 Gang Liu, 1 Jing Wang, 1 Bingyang Ji 1 1 Department of Cardiopulmonary Bypass, Fuwai Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Cardiovascular Disease, Beijing, People's Republic of China; 2 Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China; 3 Department of Pain, Beijing Jishuitan Hospital, Capital Medical University, Beijing, People's Republic of China; 4 Department of Information Center, Fuwai Hospital, Chinese Academy of Medical science and Peking Union Medical College, National Clinical Research Center for Cardiovascular Disease, Beijing, People's Republic of China Correspondence: Bingyang Ji, Department of Cardiopulmonary Bypass, Fuwai Hospital, No. 167 Beilishi Road, Xicheng District, Beijing, 100037, People's Republic of China, Email Purpose: There is currently no consensus on the most appropriate blood transfusion strategy for older adults undergoing cardiovascular surgery. We aimed to investigate the potential benefits of the patient blood management (PBM) program specifically for advanced age patients, and to evaluate the relationship of age and PBM in cardiovascular surgery. Patients and Methods: We collected data from patients over 60 years old who underwent on-pump cardiovascular surgery. We compared transfusion and clinical outcomes between the pre-PBM and post-PBM groups using a propensity score matching method. Then, we conducted a subgroup analysis within the original cohort, specifically focusing on patients aged of 75 and above with multivariable adjusted models. Results: Data of 9703 older adults were analyzed. Red blood cell (RBC) transfusion rates during cardiopulmonary bypass (CPB) (31.6% vs 13.1%, P< 0.001), during the operation (50.8% vs 39.0%, P< 0.001) and after the operation (5.6% vs 3.1%, P< 0.001) were significantly reduced, and mortality and the risk of some adverse events were also reduced after the PBM. Subgroup analysis showed that there was no interaction between age and PBM, and advanced age (over age 75) did not modify the effect of PBM program in reducing RBC transfusion (Pinteraction=0.245), on mortality (Pinteration=0.829) and on certain complications. Conclusion: The comprehensive PBM program could reduce RBC transfusion without adverse outcomes in older patients undergoing CPB. Even patients over age 75 may benefit from a more stringent transfusion indication. Comprehensive blood conservation measures should be applied to optimize the blood management for older patients. Keywords: cardiopulmonary bypass, cardiovascular surgery, older adults, patient blood management, red blood cell transfusion Older adults exhibit unique physiological characteristics, including reduced functional reserve, diminished compensatory capacity, and increased vulnerability to complications. 1 Within this population, including those undergoing cardiovascular surgery, there is limited tolerance to anemia. Anemia has been linked to unfavorable outcomes such as mortality, acute kidney injury, and respiratory insufficiency. 2–4 However, it is important to note that blood transfusion itself can pose risks for postoperative adverse events. 5,6 Consequently, it becomes crucial to strike a balance between managing anemia and determining an appropriate transfusion threshold specifically for older adults. Several studies have provided contrasting findings regarding the optimal blood transfusion strategy for older surgical patients. Some studies have indicated that a liberal transfusion strategy, with a hemoglobin threshold between 85–100 g/L, yields more favorable outcomes. 7–9 On the other hand, other studies have suggested a restrictive blood transfusion approach, with a hemoglobin threshold between 65–75 g/L. This latter strategy has not been associated with an increase in the risk of adverse outcomes while reducing the utilization of blood products. 10,11 Consequently, a consensus regarding the most appropriate blood transfusion strategy for older patients has yet to be reached. Further research and evidence are required to guide clinical practice and inform the decision-making process in this population. In our previous study, we have demonstrated remarkable results of a comprehensive patient blood management (PBM) program during the period of cardiopulmonary bypass (CPB) for cardiovascular surgery patients. 12 This study focused on older patients aged 60 years and above, with further subgroups analyses for those aged 60 to 74 and -Abstract Truncated-
geriatrics & gerontology,gerontology